The optimal gynecological surveillance strategy in female PJS patients remains debated and the benefits of surveillance remain to be established. Therefore, it is recommended that surveillance is conducted by a gynecologist who is experienced in the particular cancer risks that PJS patients face in the framework of a study or registry. Level of evidence: low Strength of recommendation: strong